Detalhe da pesquisa
1.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Lancet
; 403(10421): 31-43, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048793
2.
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer.
Breast Cancer Res
; 23(1): 8, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33451345
3.
Cell proliferation inhibitors and apoptosis promoters.
EJC Suppl
; 15: 73-76, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33240445
4.
Immunotherapies in ovarian cancer.
EJC Suppl
; 15: 87-95, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33240447
5.
Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer.
Breast Cancer Res Treat
; 160(1): 69-77, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27628192
6.
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer.
Clin Cancer Res
; 30(4): 754-766, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921755
7.
Systemic treatment of newly diagnosed advanced epithelial ovarian cancer: From chemotherapy to precision medicine.
Crit Rev Oncol Hematol
; 158: 103209, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33388455
8.
Aurora kinases in ovarian cancer.
ESMO Open
; 5(5): e000718, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087400
9.
Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review.
Ann Transl Med
; 8(24): 1712, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33490224
10.
GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer.
Future Sci OA
; 5(2): FSO370, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30820349
11.
A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers.
Clin Cancer Res
; 24(9): 2050-2059, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29066505
12.
ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.
Clin Cancer Res
; 24(11): 2517-2529, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29581135
13.
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation.
Cell Metab
; 26(4): 633-647.e7, 2017 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28978427
14.
Primary paraesophageal Ewing's sarcoma: an uncommon case report and literature review.
Onco Targets Ther
; 8: 1053-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25999740
15.
EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells.
PLoS One
; 10(6): e0130543, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26110767
16.
Correction: ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.
Clin Cancer Res
; 25(4): 1431, 2019 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770490
17.
Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.
Cancer Treat Rev
; 38(6): 698-707, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22178455
18.
Trastuzumab subcutáneo: revisión de los datos clínicos y de preferencia / Subcutaneous trastuzumab: a review of the clinical and preference data
Rev. senol. patol. mamar. (Ed. impr.)
; 27(3): 131-137, jul.-sept. 2014.
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-125066
19.
Treatment of cervical cancer: the importance of a multidisciplinary team approach.
Clin Transl Oncol
; 13(7): 431-3, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21775268